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Västra G€otaland, Sahlgrenska University Hospital/ €Ostra, Gothenburg, Sweden
Received 18 March 2020; accepted 7 May 2020; Accepted Article online 18 May 2020
Abstract
Aim The goal of this European Society of Coloproctol-
ogy (ESCP) guideline project is to give an overview of
the existing evidence on the management of diverticular
disease, primarily as a guidance to surgeons.
Methods The guideline was developed during several
working phases including three voting rounds and one
consensus meeting. The two project leads (JKS and EA)
appointed by the ESCP guideline committee together
with one member of the guideline committee (WB)
agreed on the methodology, decided on six themes for
working groups (WGs) and drafted a list of research
questions. Senior WG members, mostly colorectal sur-
geons within the ESCP, were invited based on publica-
tion records and geographical aspects. Other specialties
were included in the WGs where relevant. In addition,
one trainee or PhD fellow was invited in each WG. All
six WGs revised the research questions if necessary, did
a literature search, created evidence tables where feasi-
ble, and drafted supporting text to each research
question and statement. The text and statement proposals
from each WG were arranged as one document by the
first and last authors before online voting by all authors in
two rounds. For the second voting ESCP national repre-
sentatives were also invited. More than 90% agreement
was considered a consensus. The final phrasing of the
statements with < 90% agreement was discussed in a con-
sensus meeting at the ESCP annual meeting in Vienna in
September 2019. Thereafter, the first and the last author
drafted the final text of the guideline and circulated it for
final approval and for a third and final online voting of
rephrased statements.
Results This guideline contains 38 evidence based consen-
sus statements on themanagement of diverticular disease.
Conclusion This international, multidisciplinary guide-
line provides an up to date summary of the current
knowledge of the management of diverticular disease as
a guidance for clinicians and patients.
Correspondence to: Johannes Kurt Schultz, Department of Gastrointestinal Surgery, Akershus University Hospital, Lørenskog, Norway.
E-mail: josc@ahus.no
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Introduction
There are currently several national guidelines available
from member countries of the European Society of
Coloproctology (ESCP) on the management of divertic-
ular disease, some of which are not updated [1–7]. The
guidelines committee of the ESCP decided in 2017 to
develop a pan-European guideline for the management
of diverticular disease, acknowledging that it will be a
compromise of different national guidelines and differ-
ent accessibilities to healthcare and medical procedures
in different healthcare systems.
Method
Two project leads (JKS and EA) were appointed by the
guideline committee at the annual ESCP meeting in
2017. Together with a representative from the ESCP
guidelines committee (WB), they assembled a team of
ESCP and United European Gastroenterology members
divided into six work groups (WGs). All WGs com-
prised a group leader, up to three researchers and a sur-
gical resident who were invited personally to participate
by the project leaders. Senior group members were spe-
cialists in colorectal surgery, gastroenterology or radiol-
ogy and were considered based on their scientific
contribution in the field. Consideration was taken to
ascertain that there was a balanced contribution of the
different nationalities within each WG. The groups cov-
ered six topics: WG I, Aetiology, follow-up including
risk for cancer; WG II, Imaging, indication and classifi-
cations, initial evaluation of diverticulitis and imaging;
WG III, Nonsurgical management of diverticulitis and
dietary recommendations; WG IV, Emergency surgery
for acute diverticulitis; WG V, Elective surgery for
diverticulitis; WG VI, Technical considerations, special
considerations. For all six WGs, research questions were
formulated and subsequently revised until all members
of the WGs agreed. Each WG conducted their literature
research and drafted statements and supporting docu-
mentation to their research questions.
Search methods and manuscript selection
Based on the research questions a literature search was
performed by the individual WGs. The literature
searches were performed using MEDLINE/PubMed/
ISI/Scopus and the Cochrane database between July
and September of 2018.
Study inclusion criteria were systematic reviews, ran-
domized clinical trials, cohort studies and case series on
the subject of colonic diverticulosis and diverticulitis.
The trainee or PhD candidate in each research group
performed an evaluation of the quality of evidence and
created evidence tables with structured summaries for
each relevant included article (supplements 1–6). The
level of evidence for each recommendation was graded
according to the levels of evidence published by the
Oxford Centre for Evidence-Based Medicine 2011 [8].
The drafting of supporting text and statements
All statements and the initial supporting text were pre-
sented at a face to face meeting of the entire team at
the ESCP annual meeting in Nice in September 2018.
The content and the strength of each statement and
recommendation were reviewed. All statements were
then revised to meet the changes requested. A first vot-
ing round with all WG members was conducted online
in February 2019. After the voting, all statements and
the supporting text were revised by the WGs taking into
account both the strength of the supporting evidence
and the expert comments from the voting round. The
results of this revision were then arranged into one doc-
ument by the first and last authors. During the summer
of 2019, all WG members and all country representa-
tives of the ESCP were invited to participate in a second
online voting round on all the statements. Based on
these surveys, all statements that reached an agreement
of more than 90% were considered to be in agreement
unless there were important reasoned objections by sin-
gle voters. All other statements were revised and dis-
cussed at a meeting during the ESCP annual meeting in
Vienna in September 2019. Following this meeting, all
statements and the supporting text were edited by the
first and last authors before the paper was sent for final
revision and approval by all the authors combined with
a third voting on revised statements.
WG I: Aetiology, follow-up including risk
for cancer – statement of the problem
and epidemiology
1.1 How is diverticular disease defined and how
should it be classified?
The evolution of new diagnostic pathways and novel
treatments has led to a diversity of terms such as asymp-
tomatic and symptomatic diverticulosis, diverticular dis-
ease, acute and chronic diverticulitis and some other
subgroup definitions. Unfortunately, this variety causes
confusion. To establish clear definitions is important in
the area of diverticula-related clinical and scientific com-
munication.
Numerous classifications and modifications describe
the various stages of diverticular disease [7,9]. The first
ª 2020 The Authors.
Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland. 22 (Suppl. 2), 5–286
ESCP guideline on diverticular disease J. K. Schultz et al.
widely used classification by Hinchey [10] was intended
as an intra-operative stratification of perforated divertic-
ulitis with abscess or peritonitis enabling surgeons to
adjust the surgical approach. It was later modified to pre-
operative use, incorporating CT findings [11]. The Ger-
man guidelines suggest a new classification that is
currently under validation. It was developed on the basis
of Hinchey/Wasvary and Hansen and Stock, and adapted
to current diagnostic and therapeutic aspects [5,12].
The ESCP guideline committee has decided neither
to create yet another classification nor to quote one of
the existing ones. All the existing classifications lack reli-
able validation and none of them is generally accepted.
The guideline committee has therefore used definitions
based on evidence as far as possible with some overlap
with existing classifications. Figure 1 displays terms used
in this guideline project.
Diverticulosis vs diverticular disease
Diverticulosis of the colon (existence of false diverticula –
outpouchings of mucosa and serosa through openings in
the muscular layer of the bowel) develops in the majority
of individuals in western countries with increasing age
and usually remains asymptomatic [13,14]. Diverticulosis
per se should not therefore be considered a disease. The
term diverticular disease implies that there are symptoms
related to the diverticula.
Symptomatic uncomplicated diverticular disease
(SUDD)
Whether diverticula can lead to symptoms in the
absence of inflammation or bleeding is controversial
[15–17]. The term symptomatic uncomplicated diver-
ticular disease (SUDD) is used in some countries for
patients with diverticula who experience abdominal
symptoms (e.g. abdominal pain and bloating) and
changes in bowel habit (e.g. diarrhoea, constipation or
alternating bowel habit) in the absence of inflammation
[3,18]. However, the term has not found general accep-
tance and a uniform definition does not exist [15]. A
major difficulty is the differential diagnosis between irri-
table bowel syndrome (IBS) and SUDD as there is an
overlap between the two [18]. Epidemiological studies
have shown that IBS-like symptoms may develop after a
bout of acute diverticulitis [19]. A comparative study
between SUDD and IBS found significantly different
pain characteristics [20] with abdominal pain lasting
> 24 h occurring more frequently in SUDD, but a
recent large cohort study including individuals in a
colonoscopy screening programme found no association
between diverticulosis and abdominal pain [15]. Cur-
rently, there is little evidence on how to manage
SUDD.
Diverticulitis. The term diverticulitis describes a peridi-
verticular inflammation of the bowel wall and usually
the surrounding tissue. The theory that the inflamma-
tion is a result of translocation of intestinal bacteria
through the mucosa of the diverticulum on the basis of
a weak barrier has lately been challenged [21] and the
true aetiology is unclear.
Diverticulitis can be acute or chronic and compli-
cated or uncomplicated with possible complications
including abscess, perforation, fistulas, obstruction and
bleeding [3]. The severity of acute diverticulitis, mainly
determined by cross-sectional imaging (CT scan, ultra-
sound) and laboratory tests (C-reactive protein), is deci-
sive and guides management and treatment. In general,
uncomplicated acute diverticulitis is differentiated from
complicated acute diverticulitis. The cut-off is poorly
defined but depends on the degree of inflammation.
Acute uncomplicated diverticulitis. Acute uncomplicated
diverticulitis is inflammation in a diverticula-bearing
Figure 1 List of terms and stages used
in the guideline. The flowchart shows the
different stages of diverticulosis and
diverticular disease. Note that although
diverticulosis is a conditio sine qua non
for the other stages, the different stages
are not part of a continuous development
and may appear independently in
individual cases. *The term SUDD is
controversial, as it remains unclear
whether this is a disease of its own or
whether it represents the coexistence of
irritable bowel syndrome and
diverticulosis.
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bowel segment and the surrounding tissue without
signs of perforation (extraluminal air) or abscess forma-
tion.
Acute complicated diverticulitis. Typical complications
of acute diverticulitis occur if the inflammatory process
extends beyond the colonic wall. However, peridivertic-
ulitis alone is not considered complicated disease. A
covered perforation with air bubbles in proximity to the
bowel, intra-abdominal abscess adjacent to the inflamed
segment (Hinchey Ib, according to Wasvary) or distant
(Hinchey II) and free perforations with purulent or fae-
cal peritonitis (Hinchey III and IV) represent the major
manifestations of acute complicated diverticulitis [11].
Chronic diverticulitis. If an acute diverticulitis does not
resolve completely, chronic diverticulitis can develop.
Wall thickening or chronic mucosal inflammation in the
absence of stenosis is called chronic uncomplicated diver-
ticulitis. Complicated chronic diverticulitis includes both
stenotic disease, which may lead to acute bowel obstruc-
tion, and fistulation most commonly to the urinary tract.
Diverticular bleeding. Diverticular bleeding is reported
to account for about 35% of painless lower gastrointesti-
nal bleeding and occurs in up to 50% of elderly patients
with diverticulosis [5]. The exact incidence is difficult
to estimate, however. Frequently, the bleeding site can-
not be identified, and coexisting diverticula may then
falsely be reported as the bleeding cause.
Diverticular bleeding is arterial and occurs from rup-
ture of the intramural branches of the marginal artery at
the dome or neck of the diverticulum. Trauma from
mechanical or chemical causes within the lumen of the
diverticulum leads to injury to the penetrating vessels
and bleeding. Histopathological examination of divertic-
ular bleeding sites has shown absence of diverticulitis
[22], but bleeding may occur during inflammation as
well. If surgery is required, precise localization of the
bleeding site is crucial for any surgical procedure. Colo-
nic resections in patients with diverticular bleeding and
an unclear localization have shown a postoperative mor-
tality of 43% in comparison to 7% in patients with
defined bleeding localization [23]. There are separate
guidelines for the management of lower gastrointestinal
bleeding which is therefore not part of this guideline.
The following statements are definitions by agree-
ment of the guideline group.
Statements
1.1.1 Diverticulosis means an asymptomatic presence
of diverticula and is per se not a disease.
Agreement 97% (second voting)
1.1.2 Diverticular disease is defined as diverticulosis
with related symptoms or complications.
Agreement 100% (consensus meeting)
1.1.3 Clinical and scientific communication on
diverticular disease must use accepted definitions.
Agreement 100% (second voting)
1.1.4 It is unclear whether SUDD – as defined by
abdominal symptoms without proven inflammation
or bleeding – can be considered a disease of its own
or whether it represents the coexistence of IBS and
diverticulosis.
Evidence level 4. Agreement 100% (consensus meet-
ing)
1.1.5 Diverticulitis should be associated with symp-
toms and signs of peridiverticular inflammation pro-
ven by cross-sectional imaging and laboratory tests.
Diagnosis should differentiate between uncompli-
cated and complicated as well as acute and chronic
diverticulitis.
Evidence level 4. Agreement 97% (second voting)
1.1.6 Diverticular bleeding, very probably caused
by a mechanical disruption of a vessel, occurs
mostly painlessly without preceding diverticulitis.
Patients with possible diverticular bleeding often
need hospitalization with multidisciplinary treat-
ment options and an urgent or semi-urgent endo-
scopic evaluation.
Evidence level 4. Agreement 93% (second voting)
1.2 What is the prevalence of diverticulosis?
By far the majority of individuals with diverticulosis
remain asymptomatic throughout life [12]. Therefore,
the incidence of diverticulosis is difficult to estimate.
Most data come from autopsy studies. A prospective
study from Taiwan in asymptomatic subjects undergo-
ing colonoscopy for a health screening revealed a fre-
quency of colonic diverticulosis of 256 out of 1899
asymptomatic subjects (13.5%) ranging from 4.9% in
young adults (< 39 years) to 74.4% in the group
> 70 years of age. There was a clear preponderance of
men [24]. In western countries with a predominant
Caucasian population, the prevalence is higher [14,15].
Estimated rates of diverticulitis in patients with known
diverticulosis are as low as 1%–4% or 1.5–6.0 per 1000
patient-years [25].
Diverticulosis and associated clinical problems are
most likely to occur in older age groups. However,
although diverticula still are most frequent in elderly
individuals, evidence is emerging that the condition has
increased particularly in younger subjects under
45 years of age [26].
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1.3 What is the incidence of uncomplicated and
complicated diverticulitis and what are the annual
healthcare costs for diverticulitis in Europe?
Although there is quite a variability of frequency rates
for diverticulitis in the literature, there is some evidence
that the incidence of diverticulitis has risen over the last
years particularly in younger adults and women. There
are almost no population-based data. Nearly all studies
refer to the number of hospital admissions (Data S1,
1.3a). A recent Italian study found an overall rate of 48
hospital admissions for acute diverticular disease per
100 000 inhabitants in 2015, and a yearly increase of
over 3% from 2008. Interestingly, the age-specific rate
was constant for older ages and there was only a slight
increase for the younger age groups; thus some of the
increase of the overall rate might be attributed to the
aging population. The overall rate of hospital admis-
sions for acute diverticular disease per 100 000 hospital-
izations was 248 with an annual increase of 7.5% from
190 in 2008 to 310 in 2015 [27]. From the USA, a
prevalence of 92/100 000 persons with a preponder-
ance of women has been reported [28].
In the Netherlands, approximately 22 000 patients
per year are referred to secondary care with diverticuli-
tis. Ten per cent of these patients will develop complica-
tions such as abscess or perforation and will require
further treatment in the form of close observation,
antibiotics, percutaneous drainage or surgery [29]. Due
to uncertainties about the incidence, it is difficult to
estimate the health economic burden of diverticulitis
and there are no reliable calculations (Data S1; 1.3b).
1.4 What are the risk factors for diverticulosis,
diverticulitis and its complications?
The formation of diverticula and the pathogenesis of
diverticular disease is multifactorial and as yet not com-
pletely understood (Data S1; 1.4). Traditionally, the
factors are thought to include older age, environment
(diet, physical activity) and intestinal motility. Obesity is
a major risk factor with a linear relationship and a rela-
tive risk for each 5-unit body mass index increase of
1.28 (95% CI 1.18–1.40) for diverticular disease, 1.31
(95% CI 1.09–1.56) for diverticulitis and 1.20 (95% CI
1.04–1.40) for complicated diverticular disease (defined
as bleeding, abscess or perforation) [30]. Recent
research has identified other factors, such as genetic pat-
terns, altered tissue composition and malfunction as
associated with neuro-gastrointestinal disturbances [21].
Colonic diverticula may occur in all segments of the
colon but mostly in the sigmoid colon, with the second
most common site in the right colon [31].
For practical reasons, risk factors for the develop-
ment, appearance and outcome of acute diverticulitis
are split into noncontrollable factors (age, sex and
genetics) and factors that can be influenced.
Twin studies have demonstrated that a genetic com-
ponent is present in the development of diverticulosis
[32,33]. Few genetic studies have identified the actual
genes that are susceptible culprits. Genetic connective
tissue disorders like Ehlers–Danlos and Marfans syn-
drome have been linked to the development of divertic-
ulosis in young age [34,35]. Some studies indicated
that genes involved in immunity, extracellular matrix,
cell adhesion, membrane transport and intestinal motil-
ity may be related to diverticular disease [36–38]. How-
ever, the exact mechanisms remain to be shown.
Food and lifestyle are among the commonly discussed
controllable risk factors, particularly dietary fibre. Epi-
demiological studies indicate that dietary fibre has a pro-
tective effect against development of diverticulosis and
diverticulitis [39,40]. In addition, nuts, grains, corn and
popcorn have been shown in big cohort studies to be
protective against the development of diverticulitis [41].
Red meat and smoking are possible risk factors [21].
Obesity is a risk factor for developing diverticulosis,
diverticulitis and diverticular bleeding while physical
activity is protective [42–45].
Commonly used drugs, such as nonsteroidal anti-in-
flammatory drugs, aspirin, acetaminophen, corticos-
teroids and opioids increase the risk of diverticular
disease, particularly complicated diverticulitis [46].
In Denmark, 12%–17% of all hospitalizations for
diverticulitis are for complicated diverticulitis with a
marked increase of 43% in absolute numbers between
2000 and 2012 [47]. Similar trends have been reported
from Scotland [48].
Acute complicated diverticulitis comes with consider-
able mortality. In the largest series of Hinchey Ib-II
diverticulitis (n = 3148, nationwide Danish registry),
8.7% of patients died within 30 days from admission, and
2.5% of those discharged alive died within 30 days from
discharge; age and use of glucocorticoids were the main
independent risk factors for death in multivariate analysis
[49]. Following an episode of acute diverticulitis with
abscess formation, there is a marked risk for recurrence.
The nationwide Danish registry data show recurrence
rates of 9%–24%. Most recurrences and recurrence-re-
lated mortality occurred within the first year [50].
Mortality risk increases even more in the case of free
perforations with peritonitis. A Dutch series from 1990
to 2005 found it to be as high as 26.5% during initial
hospital stay with an overall 5-year survival of just 53%,
mainly caused by the poor general health of the patients
[51].
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Both the risk of a subsequent free perforation and
the risk of death decrease with the number of previous
episodes [49,52]. The first episode of complicated
diverticulitis is by far the most dangerous.
Statements
1.4.1 The development of diverticulosis is multifac-
torial and risk factors include age, genetic predisposi-
tion and obesity. The pathogenesis from
diverticulosis to diverticulitis and its complications
can be influenced by lifestyle and medications.
Evidence level 2. Agreement 100% (consensus meeting)
1.4.2 Acute complicated diverticulitis is associated
with considerable short-term and long-term mortal-
ity. The risk of severe complications is highest at the
first episode of diverticulitis and decreases with the
number of recurrences.
Evidence level 2. Agreement 100% (second voting)
1.5 How should patients be followed-up after an
episode of uncomplicated and complicated
diverticulitis?
Due to the generally benign course of diverticulitis a rou-
tine follow-up of the disease itself seems only justified in
unresolved complicated cases. However, although the
widespread use of abdominal CT in the acute setting has
made the diagnostics more accurate, the differentiation
between diverticulitis and colorectal cancer (CRC) is still
difficult in some cases. Most previous guidelines recom-
mended routine colonoscopy some weeks after an episode
of acute diverticulitis [6]. The rationale was that early
detection of CRC in misdiagnosed patients could reduce
the chance of dissemination. No randomized trials to
investigate the usefulness of this practice (by comparing
cancer-specific survival with and without endoscopy) exist.
Many primarily retrospective studies have investigated
detection rates for CRC with colonoscopy after acute
diverticulitis (Data S1, 1.5). However, meta-analyses of
data have been troubled by the heterogeneity of the stud-
ies, the lack of a valid reference population, inconsistent
reporting of CT verification of the diverticulitis episode,
inconsistent definitions of uncomplicated and complicated
diverticulitis and the lack of information about ongoing
symptoms in the included patients [53–57].
Routine colonoscopy after an episode of conserva-
tively treated complicated diverticulitis is generally
accepted, as the prevalence of CRC is between 7.9%
and 10.8% in this group [53,55,56].
For patients with CT verified uncomplicated divertic-
ulitis, the two most recent meta-analyses have calculated
a prevalence of CRC of 0.5% and 1.2% respectively due
to the inclusion of different studies [55,56]. Further-
more, in the meta-analyses different reference popula-
tions are used leading to different conclusions. Meyer
et al. calculated the prevalence of CRC after uncompli-
cated diverticulitis to be higher than that in the rest of
the population whereas Rottier et al. found these preva-
lences to be similar. It should be noted that the preva-
lence of undiagnosed CRC in the asymptomatic
background population can only be estimated. Detec-
tion rates of CRC in screening programmes vary
between 0.1% [58] and 1% [59] (mostly around 0.5%
[60]), depending on the age and risk profile of the
included population. Screening probably overestimates
the prevalence of CRC in asymptomatic patients, as par-
ticipation rates are usually far below 50% and symp-
tomatic and high-risk patients probably are more likely
to attend. Also, incidence rates for CRC have been used
to estimate the prevalence of undiagnosed CRC in the
population [55,61], which has the weakness that it is
uncertain how long the CRC existed before diagnosis.
After a CT verified uncomplicated diverticulitis, colo-
noscopy is usually part of the normal work-up of symp-
tomatic patients (bleeding, changed bowel habits or
ongoing pain). Controversy exists whether asymp-
tomatic patients need endoscopic follow-up.
Statement
1.5.1 Endoscopic follow-up: for patients with symp-
tom-free recovery after a single episode of CT veri-
fied uncomplicated diverticulitis endoscopic follow-
up remains controversial and may not be necessary.
All other patients treated without resection for acute
diverticulitis should be followed up with an examina-
tion of the colon at least 6 weeks after the acute epi-
sode, if not done within the last 3 years.
Evidence level 3. Agreement 100% (third voting)
WG II: Imaging, indication and
classifications – initial evaluation of
diverticulitis and imaging
2.1 How can clinical findings be correlated to the
severity of the disease?
Before the introduction of current imaging modalities,
acute diverticulitis was a diagnostic challenge [62]. A
diagnosis of acute diverticulitis based solely on clinical
findings is incorrect in more than 50% of cases [63].
Together with other clinical findings, laboratory tests
may be helpful to guide the clinician in the diagnosis
[64]. Several studies indicate that C-reactive protein
levels are correlated to the severity of disease and
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recurrence rates; however, certain discrimination
between the stages of the disease is not possible [65–
68]. Existing studies investigating the correlation
between clinical findings and staging at imaging are very
heterogeneous and generally not of high quality [29].
Clinical findings may lead the clinician, however, when
deciding the urgency of imaging and intervention.
Statement
2.1.1 There is a poor correlation between clinical
findings and severity of the disease.
Evidence level 2. Consensus 100% (consensus meeting)
2.2 When should imaging be obtained on index and
successive presentations of disease? (Which cases can
be treated in primary care without imaging?)
Due to the low diagnostic accuracy of a clinical evalua-
tion, imaging is generally required to confirm the clini-
cal suspicion of acute diverticulitis in primary and
secondary care, especially in patients with no previous
diagnosis of diverticulitis [64,69,70]. Even successive
presentation of diverticulitis may require imaging to
confirm the diagnosis. However, as the course of acute
uncomplicated diverticulitis even with small abscesses is
benign [71], and severe complications are rare with low
C-reactive protein levels, an observational strategy with-
out imaging may be adequate in mild cases, especially
in frequent recurrent disease [69]. If no imaging is
obtained, elective endoscopic examination, if not
recently done, may be helpful for differential diagnosis.
Statement
2.2.1 Imaging is required to confirm the diagnosis
of acute diverticulitis if there is no prior diagnostic
information.
Evidence level 2, Strong recommendation. Consen-
sus 100% (consensus meeting)
2.3 What is the most appropriate imaging tool to
diagnose acute diverticulitis?
CT, ultrasound and MRI are possible imaging modali-
ties that have been studied as tools to identify and clas-
sify diverticulitis. CT has a high sensitivity and
specificity in the diagnosis of acute diverticulitis [72].
Although abdominal ultrasound in expert hands has a
high diagnostic accuracy, it has not gained widespread
popularity [73]. Ultrasound has the advantages of
avoiding ionizing radiation and easy repetition if needed
and it can be useful in pregnancy [72,74]. However, it
is less accurate for abscess identification and exclusion
of other gastrointestinal issues. A modified Hinchey
classification cannot be assessed by ultrasound evalua-
tion [75,76]. MRI is highly sensitive and specific in the
differential diagnostics of diverticulitis [77]. However,
as it is time consuming and less available than CT it has
not found wide acceptance. MRI is an alternative when
ultrasound is inconclusive in pregnant women as well as
after the acute phase to assist in differential diagnoses.
Statement
2.3.1 CT is recommended as the first-line investiga-
tion in suspected diverticulitis. Ultrasound and MRI
are alternatives.
Evidence level 2, Strong recommendation. Consen-
sus 100% (consensus meeting)
2.4 Which CT classification is appropriate?
There are many classifications in the literature but most
of the published papers use either the Hinchey classifi-
cation or a modified version of it. However, the
Hinchey classification was originally a classification of
intra-operative findings in patients with perforated
diverticulitis and included only patients with abscesses
or free perforations. One should be aware that the most
frequently used modification by Wasvary also includes
mild phlegmonous disease in the absence of complica-
tions [11,78–83]. It is useful for classifying both acute
uncomplicated and complicated diverticulitis although
there is little validation.
Statement
2.4.1 No CT classification is superior to others as a
diagnostic tool for acute diverticulitis. Each centre
should choose their preferred classification in com-
munication with available radiologists.
Evidence level 5, Conditional recommendation.
Consensus 100% (third voting)
WG III: Nonsurgical management of
diverticulitis and dietary
recommendations
3.1 Should uncomplicated diverticulitis be treated
with antibiotics?
Two randomized clinical trials (AVOD [84,85] and
DIABOLO [71,86]) were performed comparing
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antibiotic and nonantibiotic treatment in immunocompe-
tent and nonseptic patients with uncomplicated acute
diverticulitis. No differences in time to recovery from the
initial episode or in hospital stay were seen in the two trials
(Data S3; 3.1). Furthermore, no differences were observed
in the two trials regarding rates of complicated diverticuli-
tis and the need for sigmoid resection after the initial
diverticulitis episode and on long term (up to 11 years), in
rates of recurrent diverticulitis, and in the need for sigmoid
resection during the initial diverticulitis episode. Slightly
but nonsignificantly more (elective) sigmoid resections
were performed in the nonantibiotic group at 24 months
(DIABOLO trial). This may have been caused by a lower
threshold for surgery in the nonantibiotic group as they
may have felt undertreated for their initial episode. Antibi-
otic-related morbidity occurred in 8.3% of patients in the
antibiotic group from the DIABOLO trial. Two recent
meta-analyses of the two randomized trials concluded that
patients can be treated safely without antibiotics [87,88].
Cross-sectional imaging to confirm the diagnosis of
uncomplicated diverticulitis was performed in both ran-
domized trials and is encouraged in this guideline (State-
ment 2.2.1). However, if imaging in mild cases is not
obtained, an observational strategy without antibiotic
treatment seems justified as there is no evidence whatso-
ever for a positive effect of antibiotics in this situation.
Statement
3.1.1 Patients with acute uncomplicated diverticulitis
do not require antibiotics routinely. Antibiotic treat-
ment should be reserved for immunocompromised
patients and patients with sepsis.
Evidence level 1, Strong recommendation. Consen-
sus 100%, consensus meeting
3.2 What is the role of antibiotics in complicated
diverticulitis?
Little evidence exists about antibiotic treatment in
patients with complicated diverticulitis. Many patients
with complicated diverticulitis are critically ill and it
seems unethical to investigate the role of antibiotics in
these patients. Patients who might be eligible for
nonantibiotic treatment are those with small abscesses
or small air bubbles around the sigmoid. In the above-
mentioned AVOD study [84], patients with radiological
signs of complications were excluded. The Dutch DIA-
BOLO trial did include patients with small abscesses on
CT [71]. However, the number of patients in this cate-
gory was very small and no final conclusions can be
drawn. There are several cohort studies investigating
patients with pericolic air, showing that they have the
same prognosis as patients with uncomplicated divertic-
ulitis [89–91]. However, in nearly all of these studies
patients were treated with antibiotics [92].
Statement
3.2.1 Patients with radiological signs of complicated
diverticulitis should normally be treated with antibi-
otics.
Evidence level 3, Conditional recommendation.
Consensus 100%, consensus meeting
3.3 Which group of diverticulitis patients can safely be
treated as outpatients?
Two recent systematic reviews [93,94] have studied the
evidence. One included 21 and the other 19 studies
including one randomized trial [95] comparing inpa-
tient and outpatient treatment for patients with uncom-
plicated diverticulitis, and comparable rates of
readmission were found. The 19 studies combined
showed a pooled readmission rate of 7%, very low rates
of surgical or percutaneous interventions (0.2%) and
potential healthcare cost savings up to 82% (Data S3;
3.3). Most studies only selected patients as outpatient
treatment candidates based on patient characteristics
(such as absence of comorbidities or immunosuppressed
state), clinical condition (such as having uncomplicated
diverticulitis and ability to tolerate oral intake) and
patients’ social environment (adequate family and social
network). The second review published in 2019
included 21 studies and found a failure rate of 4.3% but
highlighted that there were no criteria of failure, which
makes patient selection difficult.
Statement
3.2.2 For patients with an adequate social network
tolerating oral intake, outpatient treatment of
uncomplicated diverticulitis seems to be safe in the
absence of sepsis, significant comorbidity and
immunosuppression.
Evidence level 2, Conditional recommendation.
Consensus 97%, consensus meeting
3.4 Which supportive measures should be
recommended in the acute stage of diverticulitis?
Although dietary restrictions and bed rest have been
suggested as part of the treatment of acute diverticulitis,
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no benefit has ever been proven in studies. Many sur-
geons have traditionally recommended a low residue
diet, but there is little evidence to support this practice.
Two observational studies showed that an unrestricted
diet is not associated with an increase in the rate of
diverticular complications. A retrospective study showed
no increase in complications in a group of patients with
a solid food diet compared to several types of dietary
restrictions [96]. A prospective single-arm study with an
unrestricted diet found an 8.1% complication rate after
6 months, which is comparable to rates in the literature
on uncomplicated diverticulitis [97]. Additionally, a
randomized trial found no increased pain scores, no
increased length of hospital stay and no treatment fail-
ures in patients with an unrestricted oral regimen com-
pared to an intravenous regimen including a minimum
24 h of fasting [98]. Notably, this trial primarily com-
pared oral and intravenous antibiotics which may have
affected its results. Bed rest has not been studied at all.
In addition, all patients with acute uncomplicated diver-
ticulitis included in studies regarding outpatient man-
agement with or without antibiotics have had oral
antibiotics with comparable outcomes as in the litera-
ture (Data S3; 3.4).
Statements
3.4.1 There is no evidence to support dietary restric-
tions. An unrestricted diet (when tolerated) is
preferable.
Evidence level 3, Conditional recommendation.
Consensus 93% (second voting)
3.4.2. Any evidence regarding bed rest is lacking
and, since imposed physical inactivity may impair the
patients’ general condition, bed rest is not recom-
mended.
Evidence level 4, Conditional recommendation.
Consensus 100% (second voting)
3.5 Are medical agents (mesalazine, rifaximin,
probiotics) useful to prevent recurrences or persistent
symptoms after an episode of acute diverticulitis?
Several medical agents have been studied for their abil-
ity to prevent recurrent diverticulitis or persistent symp-
toms after an episode of acute diverticulitis: mesalazine
(anti-inflammatory agent), rifaximin (nonsystemic,
broad-spectrum nonabsorbable antibiotic) and probi-
otics (Data S3; 3.5). Mesalazine has been studied most
thoroughly. A recent systematic review including seven
randomized trials showed a pooled risk ratio for recur-
rent diverticulitis of 0.90 (95% CI 0.61–1.33) for mesa-
lazine treatment compared to no treatment or placebo
[99]. Mesalazine may reduce global symptom scores.
This has only been investigated by two trials including
few patients (77 mesalazine and 76 control patients)
[100,101]. The effect of 7–10 days per month rifaximin
was assessed in one proof-of-concept randomized clini-
cal trial [102] (rifaximin vs placebo) and two observa-
tional studies [103,104] (rifaximin vs mesalazine). The
randomized clinical trial found no difference in recur-
rent diverticulitis rates at 48 weeks in the intention-to-
treat analysis, although some benefit of rifaximin was
seen in additional analyses that were adjusted for several
confounders. However, the number needed to treat is
high and it is hence not clinically useful. The two obser-
vational studies comparing rifaximin and mesalazine
found opposite results – one was in favour of rifaximin
and the other in favour of mesalazine. Probiotics have
been the topic of two randomized trials demonstrating
conflicting results. One trial compared a combination of
probiotics and mesalazine with mesalazine monotherapy
[101]. The probiotics/mesalazine group yielded the
highest rate of recurrent diverticulitis and gastrointesti-
nal complaints. The other trial found lower rates of
recurrent diverticulitis in the probiotics group compared
to the control (no treatment) group, but this trial
included only 43 and 40 patients per group respectively
and followed patients for only 3 months [105].
Statement
3.5.1. From the available medical agents, neither
mesalazine, rifaximin nor probiotics can be recom-
mended to prevent recurrent diverticulitis or persis-
tent complaints after an episode of acute
diverticulitis.
Evidence level 3, Conditional recommendation.
Consensus 96% (second voting)
3.6 Should a high-fibre diet be recommended
following an episode of acute diverticulitis?
A recent systematic review identified only two random-
ized studies assessing the effect of fibre modifications
following an episode of acute diverticulitis [106]. Both
studies were conducted over 30 years ago and included
only 20 and 56 patients, respectively. A three-arm ran-
domized cross-over intervention study showed a higher
proportion of patients being symptom free after
1 month of fibre supplements compared to a high-fibre
diet. A retrospective cohort study demonstrated a lower
recurrence rate in patients adhering to a high-fibre diet
compared to patients not adhering to this diet [107].
This is in line with large epidemiological cohort studies
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concluding that a high-fibre diet is associated with a
lower risk of diverticular disease [39,40,108]. Although
this evidence suggests that a high-fibre diet may be ben-
eficial in the prevention of diverticulitis and its recur-
rence or persistent symptoms, no final conclusions can
be drawn due to the limitations of these studies.
Statement
3.6.1 Although a high-fibre diet may be recom-
mendable for general health purposes, there is little
evidence that it can prevent recurrent episodes or
persistent symptoms in patients with acute divertic-
ulitis.
Evidence level 3, Conditional recommendation.
Consensus 93% (second voting)
3.7 What is the appropriate treatment strategy for
patients with a diverticular abscess in the acute
setting?
The management of acute diverticulitis with abscess for-
mation consists of two different topics: how to manage
these abscesses in the acute stage of disease and whether
to perform an elective resection due to the complicated
nature of this initial episode (see Statement 5.2.1).
Diverticular abscesses can initially be treated with antibi-
otics and/or percutaneous drainage and/or surgery. A
great number of studies have assessed the risk of treat-
ment failure in one or more of these treatment strate-
gies. However, no randomized data are available, and
the observational studies suffer from high risk of selec-
tion bias (Data S3; 3.7). In almost all studies abscesses
are larger and patients more severely ill in percutaneous
drainage groups compared to the antibiotic groups, and
in the surgical groups compared to nonsurgical groups,
hampering the comparison of outcomes between these
groups. A recent systematic review including 42 studies
found comparable rates of treatment failure for antibi-
otics (19.9%), percutaneous abscess drainage (20.8%)
and nonoperative management (20.6%) [109]. Mortality
rates increased with increasing invasiveness of treatment:
0.6% for antibiotics, 1.1% for nonoperative, 1.6% for
percutaneous drainage and 12.1% for surgery. A recent
large multicentre observational study including 447
patients demonstrates a significantly higher rate of treat-
ment failure in the percutaneous drainage group com-
pared to antibiotic treatment group (36% vs 24%,
P = 0.013) and more complications in a subgroup of
patients with a large or distant abscess (Hinchey II)
when undergoing percutaneous drainage compared to
antibiotics (12% vs 4%, P = 0.032), although these
results were probably affected by selection bias as previ-
ously mentioned [110]. In an attempt to eliminate this
selection bias as much as possible in observational data,
a multivariate analysis has been performed showing that
percutaneous drainage was not independently associated
with treatment failure (OR 1.47, 95% CI 0.81–2.68).
In addition to earlier studies indicating 3 cm as the best
cut-off above which treatment failure is more likely,
multivariate analysis in this study showed an abscess
cut-off size of 3 cm as the best predictor for treatment
failure and 5 cm for the need for emergency surgery.
However, in subgroups of patients with abscesses larger
than 3 and 5 cm, respectively, percutaneous drainage
was not able to decrease the rates of treatment failure.
In summary, the risk of adverse outcomes increases with
abscess size, but the role of percutaneous drainage
remains unclear.
Statement
3.7.1 Although the role of percutaneous drainage of
abscesses in acute diverticulitis is not completely
clear, it may be considered in patients with an
abscess larger than 3 cm. Emergency surgery should
be kept as last resort for patients failing other non-
surgical treatments.
Evidence level 3, Conditional recommendation.
Consensus 100% (consensus meeting)
WG IV: Emergency surgery for acute
diverticulitis
4.1 What are the indications for abdominal
exploration in patients with acute diverticulitis?
Clinical evaluation alone is very subjective and has
not been assessed in many studies. Traditionally, clin-
ical signs of sepsis in combination with generalized
peritonitis were considered an indication for surgery.
This practice is based on experience rather than evi-
dence. Radiologically detected extraluminal air has
usually been considered as a sign of perforation with
indication for surgery. There is little evidence, how-
ever, whether pericolic or free air alone is an indica-
tion for exploration or not. If extraluminal air is
used as a surrogate marker for abdominal explo-
ration, there are five retrospective and three prospec-
tive cohort studies with a total of 1470 patients
[89–91,111–115]. Most of the studies are of poor
quality with a low number of patients (Data S4;
4.1). Between 0% and 10% of all patients required a
surgical procedure.
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Free fluid has been suggested to be another surro-
gate marker, but it is frequently found in uncomplicated
diverticulitis as well, rendering the use as a surrogate
marker for complicated disease difficult [84].
Statement
4.1.1 It seems fairly safe to observe immunocompe-
tent haemodynamically stable patients even if there
are radiological signs of extraluminal air. Immediate
surgery should be considered in haemodynamically
unstable or septic patients.
Evidence level 3, Conditional recommendation.
Consensus 100% (second voting)
4.2 Which surgical approach is appropriate in patients
with faecal peritonitis (overt perforation)?
There are no randomized trials that involve nonsurgical
or nonresectional treatment for faecal peritonitis [116–
119]. Some patient series have investigated laparoscopic
closure of a perforation combined with laparoscopic
lavage but there is little evidence to support this prac-
tice [120]. There are some studies suggesting damage
control with a second look within a couple of days
[116,121]. Neither are established techniques. There
are no randomized trials comparing the laparoscopic vs
the open technique for faecal peritonitis and existing
nonrandomized trials are heavily influenced by selection
bias.
Statement
4.2.1 The surgical approach in patients with faecal
peritonitis should be related to the experience of the
surgeon; there is no evidence supporting laparo-
scopic or open surgery. Resection is the treatment of
choice.
Evidence level 4, Strong recommendation. Consen-
sus 97% (second voting)
4.3 Which surgical approach is appropriate in patients
with purulent peritonitis?
There are three recently published randomized trials
comparing laparoscopic lavage to open surgery with sig-
moid resection with or without primary anastomosis
(Data S4; 4.3). In the three studies, a total of 358
Hinchey III patients were included of whom 185
underwent laparoscopic lavage [122–124]. Several
meta-analyses have been performed with somewhat dif-
ferent results [125–133]. There are several
noncomparative cohorts showing that laparoscopic
lavage is feasible in selected patients [134].
Laparoscopic lavage reduces the risk for colostomy at
1- and 2-year follow-up but may in the short term
result in intra-abdominal abscesses and overlooked free
perforations or tumour perforations requiring reinter-
vention (drainage or reoperation) [135,136]. Laparo-
scopic lavage is cheaper than resection and colostomy
(Hartmann’s procedure) [137–139].
Statement
4.3.1 Laparoscopic lavage is feasible in selected
patients with Hinchey III peritonitis. Alternatively,
resection is recommended.
Evidence level 2, Conditional recommendation.
Consensus 93% (second voting)
4.4 What is the role of restoration of intestinal
continuity with or without proximal faecal diversion in
the management of acute diverticulitis?
Several studies have addressed the intestinal continuity
during surgical treatment for acute diverticulitis.
There are three cohort studies and four randomized
trials [116–119,140–142]. The randomized clinical
trials all include a diverting loop ileostomy in the pri-
mary anastomosis arm. None of the randomized clini-
cal trials found a difference in morbidity or mortality
between primary anastomosis and sigmoid resection
with colostomy. Primary anastomosis will result in a
lower stoma rate but may also increase the risk for
complications. Many studies have used a diverting
loop ileostomy. The DIVA arm of the LADIES trial
has indicated that primary anastomosis is a safe option
for Hinchey III and Hinchey IV patients compared to
resection and a stoma [142]. The larger cohort stud-
ies included both Hinchey III and Hinchey IV and
one of the cohort studies included 67 721 patients
[141]. This study found a higher risk for complica-
tions in patients with anastomosis and diversion com-
pared to colostomy.
Statement
4.4.1 Primary anastomosis with or without diverting
ileostomy can be performed in haemodynamically
stable and immunocompetent patients with Hinchey
III or IV diverticulitis.
Evidence level 2, Conditional recommendation.
Consensus 97% (second voting)
ª 2020 The Authors.
Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland. 22 (Suppl. 2), 5–28 15
J. K. Schultz et al. ESCP guideline on diverticular disease
WG V: Elective surgery for diverticulitis
5.1 When should elective sigmoid colectomy be
considered after recovery from uncomplicated acute
diverticulitis?
Previously elective colon resection after the second epi-
sode of uncomplicated diverticulitis in order to prevent
severe attacks was widely recommended [79,143,144].
While sigmoid resection is effective to reduce the risk of
recurrent attacks of diverticulitis, several cohort studies
have shown that complications are most likely to occur
at the first episode and prophylactic surgery to prevent
complications is not indicated [52,145]. The only justi-
fiable reason to operate on patients with recurrent dis-
ease or with ongoing symptoms after uncomplicated
diverticulitis is to improve their quality of life (QoL).
There are numerous retrospective cohort studies on
elective surgery [146–151], some of them addressing
QoL [150,151] (Data S5, 5.1). These studies are very
heterogeneous and of low quality, with a high probabil-
ity of selection bias and inconsistent findings [152].
Recently the short- and long-term results of the
DIRECT trial have been published. This is the only
randomized trial comparing elective surgery vs conserva-
tive management of patients with frequently recurrent
diverticulitis or ongoing symptoms after an episode of
diverticulitis [153,154]. The QoL after 6 month and
after 5 years was significantly better for patients in the
surgical group. However, the trial had several limita-
tions. It was prematurely aborted, had a relatively small
sample size and the observed difference in QoL
between the groups was quite small. Furthermore, the
inclusion criteria were very strict, only patients with fre-
quent recurrences (more than two within 2 years) or
patients with ongoing symptoms and radiologically or
endoscopically proven ongoing inflammation were eligi-
ble. The complication rate in the operative group was
high (15% anastomotic leakages).
Statements
5.1.1 Elective surgery to prevent complicated disease
is not justified, irrespective of the number of previ-
ous attacks.
Evidence level 2, Strong recommendation, Consen-
sus: 97% (second voting)
5.1.2 There is no evidence to support resection in
symptomatic patients without radiological or endo-
scopic signs of ongoing inflammation, stenosis or
fistula.
Evidence level 3, Strong recommendation. Consen-
sus 97% (second voting)
5.1.3 The goal of elective surgery after one or more
episodes of diverticulitis is to improve QoL. The
indication should be individualized and based on the
frequency of recurrences, duration and severity of
symptoms after the attacks and the comorbidity of
the patient.
Evidence level 3, Strong recommendation. Consen-
sus97% (second voting)
5.2 Should elective colectomy typically be
offered/considered after recovery from a
conservatively managed episode of acute complicated
diverticulitis?
Traditionally most patients with acute complicated
diverticulitis were treated with emergency surgery,
which before the era of cross-sectional imaging was the
only way to diagnose complicated disease with certainty
[10]. The introduction of CT and transcutaneous
treatment of abscesses has revolutionized the treatment
of abscesses and acute surgery is rarely required in
these patients. It is quite likely that the frequent use of
CT has also led to a stage migration, as the detection
of small amounts of extraluminal air and small
abscesses is much easier with up to date multidetector
CT scanning. Many patients with covered perforations
or even with distant free air are now initially treated
conservatively with antibiotics alone. Several previous
guidelines recommend elective resection after a compli-
cated attack but there is little evidence to support this
practice. Some retrospective cohort studies have
reported higher recurrence rates after acute compli-
cated diverticulitis (up to> 60%) compared to acute
uncomplicated diverticulitis (15%–23%) whereas others
report similar recurrence rates in both groups
[84,86,155–157]. A systematic review shows a recur-
rence rate of 25.5% in 7653 patients with diverticular
abscesses [109]. Other studies that are published later
show mostly comparable rates of 25%–30% but ranging
from 9% to 61% [50,110,158–162]. Several studies
included in the systematic review do not show an
increased risk for complications in recurrent episodes;
others [160] report a 63% complicated recurrence rate
and the previously discussed large observational study
[110] shows 43% of recurrences being complicated. It
should be noted that a substantial number of patients
can be treated nonoperatively again and the risk of
recurrence requiring acute operation following conser-
vative management of acute complicated diverticulitis is
relatively low [159,160]. There is only one small trial
which randomized patients with extraluminal air and/
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or abscesses to either elective surgery (n = 26) or
observation (n = 81). The majority of patients in the
observation group did not require elective surgery.
However, QoL was not evaluated in this trial [163]
(Data S5, 5.2).
Statement
5.2.1 The decision to operate on patients after a
conservatively managed episode of acute complicated
diverticulitis should follow the same principles as for
patients with uncomplicated diverticulitis, resection
is not recommended routinely.
Evidence level 3, Conditional recommendation.
Consensus 100% (second voting)
5.3 How should surgery of persisting abscesses and
fistulas be performed and is there a role for
nonsurgical treatment?
There are few high-quality studies investigating the
management of persistent abscesses and fistulas due to
diverticulitis. Some descriptive case series, focusing
either on the open or the laparoscopic approach, sup-
ported resection with primary anastomosis when possi-
ble and contextual bladder resection if needed [164–
172]. Only one small retrospective cohort study inves-
tigated laparoscopic vs open surgery, demonstrating
similar results [173]. Although limited by the poor
quality of included studies, two meta-analyses by the
same first author reported no clear advantage of the
laparoscopic approach [174,175]. Furthermore, the
authors highlighted that the laparoscopic approach
may be challenging and consequently should be per-
formed by experienced laparoscopic surgeons. There is
only scarce evidence for the use of a robotic approach
[176,177]. The conservative management of fistulas is
documented only in two older retrospective studies
[178,179]. Although limited by several sources of
bias, the results of these studies were in favour of
surgical management when the patient’s general con-
dition allows it, as the conservative treatment is
related to a high mortality rate and poor QoL (Data
S5, 5.3). There is no evidence concerning oncological
vs nononcological resection.
Statement
5.3.1 Fistulas or persistent abscesses should normally
be treated with laparoscopic or open resection of the
diseased bowel with or without anastomosis.
Evidence level 3, Conditional recommendation.
Consensus 100% (second voting)
5.4 Which surgical approach is most appropriate in
elective surgery for diverticulitis (open/laparoscopic)?
Laparoscopic sigmoid resection for the treatment of
diverticular disease is feasible in an elective setting
[180–185]. Three randomized controlled trials compar-
ing laparoscopic to open sigmoid resection have been
published [186–188]. However, they were all under-
powered, included different stages of the disease and
reported inconsistent results. Only two of these con-
clude with better short-term outcomes with laparo-
scopic resection [187,188] and none of the three
demonstrated convincing superiority of the laparoscopic
over an open approach in long-term results. Three
meta-analyses about the role of mini-invasive surgery
for elective surgery for diverticulitis have been published
[189–191], two of which included nonrandomized
studies [189,190]. The Cochrane review by Abraha
et al. [191] analysed only the three existing randomized
clinical trials. They find it uncertain whether laparo-
scopic sigmoid resection has any substantial advantage
over open sigmoid resection in diverticular disease
(Data S5, 5.4). However, laparoscopic surgery has
evolved since these trials were conducted and it is likely
that laparoscopic resection has the same short-term
advantages in diverticular disease as demonstrated for
other diagnoses.
Statement
5.4.1 Elective colon resection for diverticulitis
should preferably be performed laparoscopically
when feasible.
Evidence level 3, Conditional recommendation.
Consensus 100% (second voting)
5.5 Should immunocompromised and young patients
be treated differently?
In immunosuppressed patients, complicated diverticuli-
tis appears to be more aggressive, with more frequent
free peritoneal perforation and worse outcomes
[192,193]. The incidence of complicated diverticulitis
in patients after organ transplant is approximately 1%
higher than in immunocompetent patients [194]. Non-
operative management of renal transplant patients with
uncomplicated diverticulitis is safe, with outcomes simi-
lar to immunocompetent patients. However, the opti-
mal management of renal transplant patients with
complicated diverticulitis remains unclear as both treat-
ment choices and complication rates differed from
immunocompetent patients [195]. Comparison of
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elective colectomy in transplant patients after one epi-
sode vs multiple attacks of diverticulitis showed no dif-
ferences in complication rates and mortality. Colectomy
after a single attack of diverticulitis in transplant patients
is not justified as the operative risk is higher in these
patients [196].
Among immunocompromised patients, chronic corti-
costeroid users have the highest risk of emergency sur-
gery and of recurrence, especially in the first year after a
diverticulitis attack. There should be a low threshold for
abdominal CT in their follow-up, to search for persis-
tent fluid collections or pericolic inflammation, in which
case elective surgery may be indicated [197] (Data S5;
5.5a).
In young patients elective surgery after one episode
of acute diverticulitis has been suggested due to the
supposedly higher risk of recurrences and a more
aggressive presentation [198]. In a systematic review
including 4751 patients younger and 18 328 older than
50 years of age, patients younger than 50 years substan-
tially differ from patients older than 50 years only in
the risk for recurrent disease. Although the relative risk
for requiring urgent surgery for recurrent disease may
be higher in younger patients, the absolute risk differ-
ence was relatively small (7.3% vs 4.9%) [199]. Never-
theless, controversy persists about whether younger
patients have more aggressive attacks, and the effect of
the disease on their QoL. However, recommendation of
more liberal resection in younger patients is not sup-
ported by the evidence [200] (Data S5; 5.5b).
Statement
5.5.1 The decision for elective resection after an
acute episode of diverticulitis in immunocompro-
mised and younger patients should follow the same
principles as in other patients and is not recom-
mended routinely.
Evidence level 3, Conditional recommendation.
Consensus 100% (consensus meeting)
WG VI: Technical considerations – special
considerations
6.1 What is the role of leak tests in surgery for
diverticular disease?
The literature search did not show studies assessing intra-
operative leak tests during surgery for diverticulitis (Data
S6; 6.1). However, a systematic review and meta-analysis
of 20 studies assessing intra-operative air leak test (ALT)
during colorectal surgery concluded that evidence
suggests that ALT is necessary to identify patients with a
higher risk of colorectal anastomotic leakage [201]. In
addition, another systematic review assessed ALT and
recommended intra-operative ALT, since it is relatively
simple, inexpensive and allows for intra-operative revision
of the anastomosis [202]. This is further supported by
the results of the largest randomized trial so far, compar-
ing ALT to no ALT in 145 colorectal surgery patients,
that demonstrated that ALT significantly reduces the
incidence of postoperative clinical and radiological leaks
[203]. We suggest that, in the case of a doubtful air leak,
the test should be repeated. Moreover, after a positive
ALT, a test with methylene blue might be used to exam-
ine the extent and location of the leak.
Statement
6.1.1. An ALT of the colorectal anastomosis during
surgery for sigmoid diverticulitis is recommended.
Evidence level 2, Conditional recommendation.
Consensus 93% (second voting)
6.2 Which extent of resection is appropriate in an
emergency setting?
Most literature regarding the extent of resection is
based on retrospective data of elective surgery for diver-
ticular disease [204–209]. A recent case–control study
did not show histological inflammation or diverticula at
the resection margins to be correlated with the occur-
rence of anastomotic stenosis [206]. Extending margins
in the case of extensive diverticulosis seems unnecessary
to prevent recurrent diverticulitis [209]. However, with
regard to the construction of an anastomosis, it seems
important to resect the grossly inflamed bowel segment
both proximally and distally. Limited data are available
on the proximal resection margin, whereas more data
are available on the distal margin. Evidence from studies
comparing colo-sigmoid and colorectal anastomoses
suggests that the latter has a lower frequency of recur-
rent disease [204] (Data S6; 6.2).
Statements
6.2.1 In the emergency setting, the focus is to con-
trol sepsis and resect the perforated segment.
Evidence level 4, Conditional recommendation.
Consensus 100% (consensus meeting)
6.2.2 In the case of resection and primary anastomo-
sis, sigmoid resection down to the rectum with col-
orectal anastomosis should be done, with the
proximal margin in as healthy colon as possible.
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Evidence level 3, Strong recommendation. Consen-
sus 100% (consensus meeting)
6.3 What is the preferred vascular approach in
surgery for diverticular disease?
A meta-analysis, published in 2012, indicates no sig-
nificant difference in anastomotic leak rate between
preservation or ligation of the inferior mesenteric
artery (IMA) [210]. Results from a randomized, con-
trolled trial comparing IMA preservation and ligation
in patients undergoing surgery for diverticulitis (note
that Hinchey III/IV were not included) show an
improvement in intestinal function through a reduc-
tion in neo-sigmoid denervation [211]. Results from a
comparable randomized trial show clinical and radio-
logical leakage rates to be lower in the IMA preserva-
tion group [212]. More recent evidence, from both
retrospective and prospective cohort studies, was either
in favour of IMA preservation or inconclusive on its
effect compared to IMA ligation [213–217]. A recent
review and meta-analysis failed to demonstrate a statis-
tically significant difference in the anastomotic leakage
rate comparing IMA preservation with IMA ligation
[218]. The authors conclude that, to date, there is
insufficient evidence to recommend the IMA-preserv-
ing technique as mandatory in resection for left-sided
colonic diverticular disease and the decision remains at
the discretion of the operating surgeon. High ligation
seems warranted in cases with diagnostic uncertainty
or when cancer cannot be excluded (inconclusive CT,
MRI or endoscopy), whereas IMA preservation might
be beneficial in cases where the diagnosis is clear
(Data S6; 6.3).
Statement
6.3.1 In cases where there is no suspicion of cancer,
IMA-preserving surgery can be performed to opti-
mize preservation of the vascularization and the
autonomic nerves.
Evidence level 2, Strong recommendation. Consen-
sus 97% (second voting)
6.4 What is the role of ureteral stents in elective
resection for diverticular disease?
No results from prospective, randomized trials were
available [219–222]. Results from large population-
based studies performed in the USA have shown that,
after adjustment for other patient and clinical factors,
ureteral stenting in surgery for diverticular disease is sig-
nificantly associated with a longer operative time, as well
as a longer length of stay and higher costs
[219,220,222]. Despite this, the benefits of ureteral
stent use remain unclear, since the available literature
indicates that selective stent use might have led to con-
founding by indication. Evidence identifying patient
populations that most probably benefit from ureteral
stenting is not available yet (Data S6; 6.4).
Statement
6.4.1 Ureteral stenting is not recommended as a
routine, due to increased costs and operative time,
but may be appropriate in selected cases with severe
complicated disease.
Evidence level 3, Conditional recommendation.
Consensus 100% (second voting)
6.5 Should the splenic flexure routinely be mobilized?
One retrospective study was identified that compared
routine splenic flexure mobilization with no splenic
flexure mobilization in elective surgery for diverticular
disease [223]. Data were derived from a population-
based cohort, with innate risk of selection bias, and
showed splenic flexure mobilization to be safe and
feasible (Data S6; 6.5). Despite a trend towards an
increased minor morbidity rate (defined as superficial
or deep surgical site infection, pneumonia, unplanned
intubation, urinary tract infection or deep vein throm-
bosis) after splenic flexure mobilization, no difference
was found in major adverse events. One other retro-
spective study showed from univariate analysis that
splenic flexure mobilization did not seem to con-
tribute to the complication rate [224]. From the liter-
ature, it is suggested that splenic flexure mobilization
is performed on an individual basis, depending on the
anatomy, disease extent, and the potential for the cre-
ation of a tension-free anastomosis [223].
Statement
6.5.1 Partial or full mobilization of the splenic flex-
ure might facilitate the anastomosis being made of
soft and compliant descending colon, by being
brought down to the pelvic brim and anastomosed
with the rectum without tension. It is up to the
judgement of the surgeon whether this is necessary.
Evidence level 3, Conditional recommendation.
Consensus 100% (second voting)
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